Johns Hopkins Sjögren’s Center

Home / Research / A phase 2 randomized, double-blind, placebo-controlled, proof of concept study to evaluate the efficacy and safety of VIB4920 in subjects with Sjögren’s syndrome (SS)

A phase 2 randomized, double-blind, placebo-controlled, proof of concept study to evaluate the efficacy and safety of VIB4920 in subjects with Sjögren’s syndrome (SS)

For more information click HERE.

For more information about trials currently recruiting at our center, please contact Susan Robinson, Sr. Research Program Coordinator:

  •  Email: srobin95@jhmi.edu
  • Phone: 410-550-6492

Use of this Site

All information contained within the Johns Hopkins Jerome L. Green Sjogren’s Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.